» Articles » PMID: 37220637

Actions of Feeding-related Peptides on the Mesolimbic Dopamine System in Regulation of Natural and Drug Rewards

Overview
Journal Addict Neurosci
Date 2023 May 23
PMID 37220637
Authors
Affiliations
Soon will be listed here.
Abstract

The mesolimbic dopamine system is the primary neural circuit mediating motivation, reinforcement, and reward-related behavior. The activity of this system and multiple behaviors controlled by it are affected by changes in feeding and body weight, such as fasting, food restriction, or the development of obesity. Multiple different peptides and hormones that have been implicated in the control of feeding and body weight interact with the mesolimbic dopamine system to regulate many different dopamine-dependent, reward-related behaviors. In this review, we summarize the effects of a selected set of feeding-related peptides and hormones acting within the ventral tegmental area and nucleus accumbens to alter feeding, as well as food, drug, and social reward.

Citing Articles

Methylphenidate can help reduce weight, appetite, and food intake-a narrative review of adults' anthropometric changes and feeding behaviors.

Vedrenne-Gutierrez F, Yu S, Olive-Madrigal A, Fuchs-Tarlovsky V Front Nutr. 2024; 11:1497772.

PMID: 39677498 PMC: 11637853. DOI: 10.3389/fnut.2024.1497772.


Metformin in the management of antipsychotic-induced weight gain - why the 'weight'?.

Fitzgerald I, Sahm L, Ni Dhubhlaing C, ODwyer S, OConnell J, Torrens J Front Psychiatry. 2024; 15:1491417.

PMID: 39600786 PMC: 11588739. DOI: 10.3389/fpsyt.2024.1491417.


The nucleus accumbens shell: a neural hub at the interface of homeostatic and hedonic feeding.

Marinescu A, Labouesse M Front Neurosci. 2024; 18:1437210.

PMID: 39139500 PMC: 11319282. DOI: 10.3389/fnins.2024.1437210.


Dopamine Dysregulation in Reward and Autism Spectrum Disorder.

Blum K, Bowirrat A, Sunder K, Thanos P, Hanna C, Gold M Brain Sci. 2024; 14(7).

PMID: 39061473 PMC: 11274922. DOI: 10.3390/brainsci14070733.


Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.

Arillotta D, Floresta G, Papanti Pelletier G, Guirguis A, Corkery J, Martinotti G Brain Sci. 2024; 14(6).

PMID: 38928616 PMC: 11202225. DOI: 10.3390/brainsci14060617.


References
1.
Hsu R, Taylor J, Newton S, Alvaro J, Haile C, Han G . Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci. 2005; 21(8):2233-42. PMC: 2694749. DOI: 10.1111/j.1460-9568.2005.04038.x. View

2.
Vittoz N, Berridge C . Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology. 2005; 31(2):384-95. DOI: 10.1038/sj.npp.1300807. View

3.
Wanat M, Bonci A, Phillips P . CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat Neurosci. 2013; 16(4):383-5. PMC: 3609940. DOI: 10.1038/nn.3335. View

4.
Hayes D, Fee J, McCown T, Knapp D, Breese G, Cubero I . Neuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice. Addict Biol. 2011; 17(2):338-50. PMC: 3197888. DOI: 10.1111/j.1369-1600.2011.00336.x. View

5.
Bernardi R, Broccoli L, Hirth N, Justice N, Deussing J, Hansson A . Dissociable Role of Corticotropin Releasing Hormone Receptor Subtype 1 on Dopaminergic and D1 Dopaminoceptive Neurons in Cocaine Seeking Behavior. Front Behav Neurosci. 2017; 11:221. PMC: 5693884. DOI: 10.3389/fnbeh.2017.00221. View